Here’s What’s Pushing These 5 Stocks Higher Today

Page 3 of 3

TrovaGene Inc (NASDAQ:TROV)‘s stock jumped this morning on the news of an agreement between the company and America’s Choice Provider Network, which will offer patients access to its circulating tumor DNA Precision Cancer Monitoring tests. These tests detect oncogene mutations in patients that suffer from cancer and provide information necessary for better management of the disease. Shares of TrovaGene are currently trading up by roughly 30% from yesterday’s close.

Follow Cardiff Oncology Inc. (NASDAQ:CRDF)

Only six of the funds that we follow reported a long position in TrovaGene Inc (NASDAQ:TROV) at the end of September, together holding 15% of the outstanding stock of the company. Roberto Mignone is a fan of the stock, having also increased his investment by 5% to 3.29 million shares by the end of the quarter.

Disclosure: None

Page 3 of 3